Synlogic (LTS:0A8U) Cash Flow from Others : $-8.82 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Synlogic Cash Flow from Others?

Synlogic's cash flow from others for the three months ended in Mar. 2025 was $-1.04 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2025 was $-8.82 Mil.

Synlogic Cash Flow from Others Historical Data

The historical data trend for Synlogic's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlogic Cash Flow from Others Chart

Synlogic Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow from Others

Get a 7-Day Free Trial

1.72

2.36

2.38

11.07

-19.90

Synlogic Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash Flow from Others	Get a 7-Day Free Trial															-12.12	0.47	-7.41	-0.84	-1.04

Synlogic Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.82 Mil.

Synlogic Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Synlogic's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

Synlogic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synlogic Inc (LTS:0A8U) » Definitions » Cash Flow from Others

Comparable Companies

Traded in Other Exchanges

SYBX:USA

Address

PO Box 30, Winchester, MA, USA, 01890

Website

https://www.synlogictx.com

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Synlogic Headlines

No Headlines